359 related articles for article (PubMed ID: 26511274)
1. Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome.
Emmens JE; Ter Maaten JM; Matsue Y; Metra M; O'Connor CM; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JG; Givertz MM; Bloomfield DM; Dittrich HC; Todd J; van Veldhuisen DJ; Hillege HL; Damman K; van der Meer P; Voors AA
Eur J Heart Fail; 2016 Jun; 18(6):641-9. PubMed ID: 26511274
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of renal tubular damage in chronic heart failure.
Damman K; Masson S; Hillege HL; Maggioni AP; Voors AA; Opasich C; van Veldhuisen DJ; Montagna L; Cosmi F; Tognoni G; Tavazzi L; Latini R
Eur Heart J; 2011 Nov; 32(21):2705-12. PubMed ID: 21666249
[TBL] [Abstract][Full Text] [Related]
3. Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation.
Opotowsky AR; Baraona FR; Mc Causland FR; Loukas B; Landzberg E; Landzberg MJ; Sabbisetti V; Waikar SS
Heart; 2017 Mar; 103(6):434-442. PubMed ID: 27670967
[TBL] [Abstract][Full Text] [Related]
4. Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome.
Jungbauer CG; Birner C; Jung B; Buchner S; Lubnow M; von Bary C; Endemann D; Banas B; Mack M; Böger CA; Riegger G; Luchner A
Eur J Heart Fail; 2011 Oct; 13(10):1104-10. PubMed ID: 21846754
[TBL] [Abstract][Full Text] [Related]
5. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
[TBL] [Abstract][Full Text] [Related]
6. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.
Damman K; Van Veldhuisen DJ; Navis G; Vaidya VS; Smilde TD; Westenbrink BD; Bonventre JV; Voors AA; Hillege HL
Heart; 2010 Aug; 96(16):1297-302. PubMed ID: 20659949
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
[TBL] [Abstract][Full Text] [Related]
8. Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.
Ahmad T; Jackson K; Rao VS; Tang WHW; Brisco-Bacik MA; Chen HH; Felker GM; Hernandez AF; O'Connor CM; Sabbisetti VS; Bonventre JV; Wilson FP; Coca SG; Testani JM
Circulation; 2018 May; 137(19):2016-2028. PubMed ID: 29352071
[TBL] [Abstract][Full Text] [Related]
9. Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Grodin JL; Perez AL; Wu Y; Hernandez AF; Butler J; Metra M; Felker GM; Voors AA; McMurray JJ; Armstrong PW; Califf RM; Starling RC; O'Connor CM; Tang WH
JACC Heart Fail; 2015 Oct; 3(10):777-85. PubMed ID: 26449997
[TBL] [Abstract][Full Text] [Related]
10. Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure.
Sokolski M; Zymliński R; Biegus J; Siwołowski P; Nawrocka-Millward S; Todd J; Yerramilli MR; Estis J; Jankowska EA; Banasiak W; Ponikowski P
Eur J Heart Fail; 2017 Jun; 19(6):760-767. PubMed ID: 28133864
[TBL] [Abstract][Full Text] [Related]
11. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.
Lobato GR; Lobato MR; Thomé FS; Veronese FV
Braz J Med Biol Res; 2017 Mar; 50(5):e6106. PubMed ID: 28380198
[TBL] [Abstract][Full Text] [Related]
12. Urinary kidney injury molecule 1 and incidence of heart failure in elderly men.
Carlsson AC; Larsson A; Helmersson-Karlqvist J; Lind L; Ingelsson E; Larsson TE; Sundström J; Arnlöv J
Eur J Heart Fail; 2013 Apr; 15(4):441-6. PubMed ID: 23220287
[TBL] [Abstract][Full Text] [Related]
13. Renal tubular function and urinary N-acetyl-β-d-glucosaminidase and kidney injury molecule-1 levels in asthmatic children.
Demir AD; Goknar N; Oktem F; Özkaya E; Yazıcı M; Torun E; Vehapoğlu A; Kucukkoc M
Int J Immunopathol Pharmacol; 2016 Dec; 29(4):626-631. PubMed ID: 27272162
[TBL] [Abstract][Full Text] [Related]
14. Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study.
Park M; Hsu CY; Go AS; Feldman HI; Xie D; Zhang X; Mifflin T; Waikar SS; Sabbisetti VS; Bonventre JV; Coresh J; Nelson RG; Kimmel PL; Kusek JW; Rahman M; Schelling JR; Vasan RS; Liu KD; ;
Clin J Am Soc Nephrol; 2017 May; 12(5):761-771. PubMed ID: 28254771
[TBL] [Abstract][Full Text] [Related]
15. Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure.
Linzbach S; Samigullin A; Yilmaz S; Tsioga M; Zeiher AM; Spyridopoulos I
Am J Cardiol; 2009 Apr; 103(8):1128-33. PubMed ID: 19361601
[TBL] [Abstract][Full Text] [Related]
16. Associations between urinary kidney injury biomarkers and cardiovascular mortality risk in elderly men with diabetes.
Tonkonogi A; Carlsson AC; Helmersson-Karlqvist J; Larsson A; Ärnlöv J
Ups J Med Sci; 2016 Aug; 121(3):174-8. PubMed ID: 27321055
[TBL] [Abstract][Full Text] [Related]
17. N-acetyl-b-D-glucosaminidase: A potential cardiorenal biomarker with a relevant impact on ICD shock therapies and mortality.
Allgaier R; Strack C; Wallner S; Hubauer U; Uecer E; Lehn P; Keyser A; Luchner A; Maier L; Jungbauer C
Nephrology (Carlton); 2020 Dec; 25(12):888-896. PubMed ID: 32841436
[TBL] [Abstract][Full Text] [Related]
18. Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio-SHiFT study).
Brankovic M; Akkerhuis KM; Hoorn EJ; van Boven N; van den Berge JC; Constantinescu A; Brugts J; van Ramshorst J; Germans T; Hillege H; Boersma E; Umans V; Kardys I
Clin Cardiol; 2020 Jun; 43(6):630-638. PubMed ID: 32298007
[TBL] [Abstract][Full Text] [Related]
19. Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study.
Brankovic M; Akkerhuis KM; van Boven N; Anroedh S; Constantinescu A; Caliskan K; Manintveld O; Cornel JH; Baart S; Rizopoulos D; Hillege H; Boersma E; Umans V; Kardys I
Kidney Int; 2018 Apr; 93(4):952-960. PubMed ID: 29191357
[TBL] [Abstract][Full Text] [Related]
20. Effects of ivabradine therapy on heart failure biomarkers.
Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
